Tish Knobf, PhD, RN, FAAN, AOCN of the Yale School of Nursing, and Lyndsay Harris, MD, Associate Professor of Medical Oncology at Yale School of Medicine, have been awarded an $180,000 grant from Susan G. Komen for the Cure. Both members of Yale Cancer Center, Drs. Knobf and Harris are actively engaged in research that targets disparities in breast cancer for African American women. This training grant is designed to attract students to participate in research to better understand and eliminate disparate cancer outcomes.
"African American women with breast cancer have poorer clinical outcomes compared to white women," Dr. Knobf stated. "This grant offers an opportunity for students to be mentored in research aimed at understanding and reducing breast cancer disparities." Drs. Knobf and Harris will recruit students from medicine, nursing, and public health. The two-year training program aims to empower students with analytical, research, scientific, and clinical skills to effectively conduct research and translate research findings into practice.
Ambassador Nancy G. Brinker, founder and CEO of Susan G. Komen for the Cure, added "Study after study acknowledges that African American women have higher mortality rates from breast cancer – a situation that Susan G. Komen for the Cure is addressing in communities across the country. Programs like this at Yale will engage the science and public health communities, together, to understand and address these care gaps."
Dr. Knobf is Professor at YSN. Her clinical practice with women with breast cancer over the past three decades has been foundational to her program of research. Dr. Knobf’s current research targets persistent and late effects of cancer treatment in breast cancer survivors and includes a health promotion intervention for woman of color who are breast cancer survivors and a randomized controlled trial of aerobic-resistance exercise compared to a home based physical activity program on bone, body composition, metabolic risk and cardiovascular function.
Dr. Harris is a nationally recognized expert in breast cancer treatment and research. Her research focuses on the molecular classifications of breast cancer and the development of novel strategies to evaluate and treat breast cancer.
"I am excited to have the support of Susan G. Komen for the Cure to give Dr. Knobf and me the opportunity to train future leaders in cancer disparities research and care. This grant will enable us to provide targeted education to our students and will ensure they graduate with a background in cancer disparities," explained Dr. Harris.
Founded in 1982, Susan G. Komen for the Cure is the global leader in the fight against breast cancer. Including the grant awarded to Drs. Knobf and Harris, the organization has invested a total of $780,000 for research in Connecticut this year. Overall, they have invested more than $1.5 billion, making them the largest source of nonprofit funds dedicated to conquering breast cancer in the world.